Altered plasma proteins released from platelets and endothelial cells are associated with human patent ductus arteriosus

Patent ductus arteriosus is the third most common congenital heart disease and resulted from the persistence of ductal patency after birth. Ductus arteriosus closure involves functional and structural remodeling, controlled by many factors. The changes in plasma protein levels associated with PDA closure are not known. Here we for the first time demonstrate six key differential plasma proteins in human patent ductus arteriosus patients using proteomic technology and present a model to illustrate the constriction and closure of ductus arteriosus. Differentially expressed proteins were analyzed by using isobaric tags for relative and absolute quantification and validated by enzyme‐linked immunosorbent assay in new samples. The proteomic data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the data set identifier PXD008568. We found 74 upregulated and 98 downregulated proteins in the plasma of patients with PDA. Five decreased proteins (platelet factor 4, fibrinogen, von Willebrand factor, collagen, and mannose binding lectin‐associated serine protease‐2) and one increased protein (fibronectin) may increase the risk of patent ductus arteriosus. Those proteins are closely related to platelet activation and coagulation cascades, complement mannan‐binding‐lectin, and other systemic signaling pathways. Our findings for the first time indicate that the differential proteins involved in different pathways may play key roles in the nonclosure of the ductus arteriosus in humans and may be developed as biomarkers for diagnosis. All those findings may be served as the basis of understanding the etiology and pathogenesis of patent ductus arteriosus.

• Publication year

  2018

• Venue

  Journal of Cellular Physiology

• Publication date

  2018-11-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/jcp.27433PMID 30480800
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma protein profiling in patients undergoing coronary artery bypass grafting surgery and clinical significance

  2017cited by this paper
• Is there a relationship between platelet parameters and patency of ductus arteriosus in preterm infants?

  2017cited by this paper
• Effect of platelet-derived β-thromboglobulins on coagulation.

  2017cited by this paper
• Human induced pluripotent stem cell-derived cardiac tissue on a thin collagen membrane with natural microstructures.

  2016influential reference
• Patent Ductus Arteriosus – A Complex Problem in Need of a Solid Conceptual Foundation –

  2016cited by this paper
• Von Willebrand Factor--A Rapid Sensor of Paravalvular Regurgitation during TAVR?

  2016cited by this paper
• KEGG: new perspectives on genomes, pathways, diseases and drugs

  2016cited by this paper
• Plasma Proteomic Study in Pulmonary Arterial Hypertension Associated with Congenital Heart Diseases

  2016influential reference
• Platelet count and associated morbidities in VLBW infants with pharmacologically treated patent ductus arteriosus

  2016cited by this paper
• Isobaric Tags for Relative and Absolute Quantitation–Based Proteomic Analysis of Patent and Constricted Ductus Arteriosus Tissues Confirms the Systemic Regulation of Ductus Arteriosus Closure

  2015cited by this paper
• Quantitative description of thermodynamic and kinetic properties of the platelet factor 4/heparin bonds.

  2015cited by this paper
• 2016 update of the PRIDE database and its related tools

  2015cited by this paper
• Acute phase proteins altered in the plasma of patients with congenital ventricular septal defect

  2015cited by this paper
• Proteomic study reveals plasma protein changes in congenital heart diseases.

  2014cited by this paper
• Plasma fibronectin supports hemostasis and regulates thrombosis.

  2014influential reference
• Platelet-rich plasma for patent ductus arteriosus: an orthopaedic surgeon’s perspective

  2014cited by this paper
• atherosclerosis-prone sites in response to hypercholesterolemia Endothelial von Willebrand factor recruits platelets to

  2013cited by this paper
• Characterization of fibrinogen glycosylation and its importance for serum/plasma N-glycome analysis.

  2013cited by this paper
• Identification of Altered Plasma Proteins by Proteomic Study in Valvular Heart Diseases and the Potential Clinical Significance

  2013cited by this paper
• Association Between Blood Spot Transforming Growth Factor-β and Patent Ductus Arteriosus in Extremely Low-Birth Weight Infants

  2012cited by this paper
• Relationship between Platelet Count and Volume and Spontaneous and Pharmacological Closure of Ductus Arteriosus in Preterm Infants

  2012cited by this paper
• Low platelet count is associated with ductus arteriosus patency in preterm newborns.

  2012cited by this paper
• Sequence and structure relationships within von Willebrand factor.

  2012cited by this paper
• DNA microarray profiling identified a new role of growth hormone in vascular remodeling of rat ductus arteriosus

  2011cited by this paper
• Vessel remodeling in the newborn: platelets fill the gap

  2010cited by this paper
• Mannose-Binding Lectin Gene Polymorphism and Early Neonatal Outcome in Preterm Infants

  2010cited by this paper
• Platelets contribute to postnatal occlusion of the ductus arteriosus

  2010influential reference
• Plasma fibronectin depletion enhances platelet aggregation and thrombus formation in mice lacking fibrinogen and von Willebrand factor.

  2009influential reference
• T-type Ca2+ Channels Promote Oxygenation-induced Closure of the Rat Ductus Arteriosus Not Only by Vasoconstriction but Also by Neointima Formation*

  2009cited by this paper
• Prostaglandin E2-activated Epac Promotes Neointimal Formation of the Rat Ductus Arteriosus by a Process Distinct from That of cAMP-dependent Protein Kinase A*

  2008cited by this paper
• Patent ductus arteriosus: an overview.

  2007cited by this paper
• Simultaneous Activation of Complement and Coagulation by MBL-Associated Serine Protease 2

  2007cited by this paper
• Trends in neonatal morbidity and mortality for very low birthweight infants.

  2007cited by this paper
• Fibrinogen controls human platelet fibronectin internalization and cell‐surface retention 1

  2007cited by this paper
• Mechanisms Regulating the Ductus Arteriosus

  2006cited by this paper
• Generation of C5a in the absence of C3: a new complement activation pathway

  2006cited by this paper
• A novel fibrinogen Bβ chain frameshift mutation in a patient with severe congenital hypofibrinogenaemia

  2006cited by this paper
• Patent Ductus Arteriosus

  2006cited by this paper
• Mannose‐binding lectin: biology and clinical implications

  2005cited by this paper
• Complement

  2005cited by this paper
• Prevalence of congenital heart disease.

  2004cited by this paper
• Inherited deficiency of mannan-binding lectin-associated serine protease 2.

  2003cited by this paper
• Expression of prostanoid receptors in human ductus arteriosus

  2003cited by this paper
• Metabolism of PGE2 by prostaglandin dehydrogenase is essential for remodeling the ductus arteriosus

  2002cited by this paper
• VEGF regulates remodeling during permanent anatomic closure of the ductus arteriosus.

  2002cited by this paper
• Inhibition of the von Willebrand (VWF)-collagen interaction by an antihuman VWF monoclonal antibody results in abolition of in vivo arterial platelet thrombus formation in baboons.

  2002influential reference
• Mapping the Ligand-binding Sites and Disease-associated Mutations on the Most Abundant Protein in the Human, Type I Collagen*

  2002cited by this paper
• Complement. First of two parts.

  2001cited by this paper
• Mannose‐binding lectin: targeting the microbial world for complement attack and opsonophagocytosis

  2001cited by this paper
• The mannan-binding-lectin pathway of the innate immune response.

  2001cited by this paper
• Activation of the murine EP3 receptor for PGE2 inhibits cAMP production and promotes platelet aggregation.

  2001influential reference
• Cutting Edge: Complement-Activating Complex of Ficolin and Mannose-Binding Lectin-Associated Serine Protease1

  2000cited by this paper
• Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen.

  2000cited by this paper
• Tissue hypoxia inhibits prostaglandin and nitric oxide production and prevents ductus arteriosus reopening.

  2000cited by this paper
• Voltage-gated potassium channels in human ductus arteriosus.

  2000cited by this paper
• Gene transfer in utero biologically engineers a patent ductus arteriosus in lambs by arresting fibronectin–dependent neointimal formation

  1999cited by this paper
• Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less.

  1996influential reference
• Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor.

  1996cited by this paper
• Platelet adhesion to fibronectin in flow: the importance of von Willebrand factor and glycoprotein Ib.

  1995cited by this paper
• The Vermont-Oxford Trials Network: very low birth weight outcomes for 1990. Investigators of the Vermont-Oxford Trials Network Database Project.

  1993cited by this paper
• The biological and pharmacological role of nitric oxide in platelet function.

  1993cited by this paper
• Structural and functional comparison of the genes for human platelet factor 4 and PF4alt.

  1990cited by this paper
• Control of the ductus arteriosus.

  1975cited by this paper
• The Journal of Experimental Medicine A Crucial Role of Glycoprotein VI for Platelet Recruitment to the Injured Arterial Wall In Vivo

  year unknowncited by this paper

• Characteristics of neonatal necrotizing enterocolitis in relation to the presence or absence of patent ductus arteriosus

  2025cites this paper
• Variants of the promoter of MYH6 gene in congenital isolated and sporadic patent ductus arteriosus: case-control study and cellular functional analyses.

  2024cites this paper
• Platelets and ductus arteriosus closure in neonates.

  2023cites this paper
• The Patent Ductus Arteriosus in Extremely Preterm Neonates Is More than a Hemodynamic Challenge: New Molecular Insights

  2022cites this paper
• An Update on Patent Ductus Arteriosus and What is Coming Next

  2022cites this paper
• Molecular Mechanisms Underlying Remodeling of Ductus Arteriosus: Looking beyond the Prostaglandin Pathway

  2021cites this paper
• Current Controversy on Platelets and Patent Ductus Arteriosus Closure in Preterm Infants

  2021cites this paper
• The Thromboelastographic Profile at Birth in Very Preterm Newborns with Patent Ductus Arteriosus

  2020cites this paper
• Early Urinary Metabolomics in Patent Ductus Arteriosus Anticipates the Fate: Preliminary Data

  2020cites this paper
• The relationship between platelet indices and patent ductus arteriosus in preterm infants: a systematic review and meta-analysis

  2020cites this paper
• Protein Biomarkers and Risk Scores in Pulmonary Arterial Hypertension Associated with Ventricular Septal Defect: Integration of Multi-Omics and Validation.

  2020cites this paper